众生药业：上半年净利润同比增长114.96%

Core Viewpoint - Zhongsheng Pharmaceutical reported a significant increase in net profit for the first half of 2025, despite a decline in revenue, indicating strong operational efficiency and cost management [1] Financial Performance - The company achieved a revenue of 1.299 billion yuan, representing a year-on-year decrease of 4.74% [1] - The net profit attributable to shareholders was 188 million yuan, showing a remarkable year-on-year growth of 114.96% [1] Dividend Policy - The company announced plans not to distribute cash dividends, issue bonus shares, or convert reserves into share capital [1]